Mackay Shields LLC’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Mackay Shields LLC’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,710	Closed	-$164K	–	1596
2020 Q2	$164K	Buy	+1,710	New	+$127K	﹤0.01%	1385
2019 Q4	–	Sell	-4,431	Closed	-$379K	–	1501
2019 Q3	$379K	Sell	4,431 -2,397	-35%	-$256K	﹤0.01%	1308
2019 Q2	$870K	Buy	6,828 +5,138	+304%	+$740K	0.01%	1164
2019 Q1	$304K	Buy	1,690 +1,313	+348%	+$190K	﹤0.01%	1272
2018 Q4	$42K	Buy	+377	New	+$49.1K	﹤0.01%	1366
2018 Q2	–	Sell	-1,093	Closed	-$151K	–	1326
2018 Q1	$151K	Buy	+1,093	New	+$149K	﹤0.01%	1232

Other funds holding SRGA

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

CLG

Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackay Shields LLC's SRGA Position: Q3 2020 in Review

Mackay Shields LLC sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2020, closing a stake of 1,710 shares — an estimated $164K sold.

Mackay Shields LLC first reported a position in SRGA in Q1 2018 and held it in 6 quarters. The position peaked at $870K in Q2 2019. 89 funds tracked by Wall St. Rank hold SRGA as of Q3 2020.

Mackay Shields LLC reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Mackay Shields LLC sold 1,710 Surgalign Holdings, Inc. Common Stock shares in Q3 2020, an estimated $164K.
Mackay Shields LLC first reported a position in Surgalign Holdings, Inc. Common Stock in Q1 2018 and held it in 6 quarters.
Mackay Shields LLC's Surgalign Holdings, Inc. Common Stock position peaked at $870K in Q2 2019.
89 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2020.

Based on Mackay Shields LLC's 13F filing for Q3 2020, filed 4 Nov 2020.